Why BioNTech Stock Soared Today
BioNTech (NASDAQ: BNTX), one of the companies made famous for its role developing vaccines with (NYSE: PFE) during the COVID-19 pandemic, soared 20.2% through 12:50 p.m. Monday on news entirely unrelated to COVID.
The German biotech announced this morning it is partnering with pharmaceuticals giant Bristol Myers Squibb (NYSE: BMY) to "co-develop and co-commercialize" BioNTech's drug candidate BNT327 as an immunotherapy against multiple kinds of cancer.
Image source: Getty Images.
Source Fool.com
Pfizer Inc. Aktie
22,03 €
-0,07 %
Die Pfizer Inc. Aktie verzeichnet mehrere Buy-Einschätzungen, was auf eine positive Stimmung hindeutet.
Die Community erwartet für Pfizer Inc. ein Kursziel von 27 €, was eine Steigerung von über 20% gegenüber 22.03 € bedeuten würde.
